IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $154 | -100.0% | 21,851 | -48.6% | 0.01% | -87.4% |
| Q1 2021 | $1,345,000 | +345.4% | 42,480 | +553.6% | 0.10% | +187.9% |
| Q4 2020 | $302,000 | -51.0% | 6,499 | -65.3% | 0.03% | -68.9% |
| Q3 2020 | $616,000 | +13.2% | 18,711 | -5.6% | 0.11% | +68.3% |
| Q2 2020 | $544,000 | +153.0% | 19,831 | +67.9% | 0.06% | +270.6% |
| Q3 2019 | $215,000 | +117.2% | 11,814 | +13.8% | 0.02% | +183.3% |
| Q1 2019 | $99,000 | -85.5% | 10,385 | -82.9% | 0.01% | -85.7% |
| Q3 2018 | $684,000 | +273.8% | 60,812 | +166.0% | 0.04% | +320.0% |
| Q4 2017 | $183,000 | – | 22,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |